No abstract available.
Graves Disease*

No abstract available.
Graves Disease*

Graves' disease (GD) and Guillain-Barre syndrome (GBS) are both autoimmune disorders and are triggered by interactions between genetic and environmental factors. GBS in patients who suffer from other autoimmune diseases is rarely reported, and the development of atypical GBS with cranial nerve involvement in a patient with GD has never been previously reported. Herein, we report a patient with GD and a rare form of pharyngo-cervico-brachial variety of GBS.

No abstract available.
Diagnosis* ; Graves Disease* ; Korea*

No abstract available.
Genetics* ; Graves Disease*

Studied on 360 patients Basedow in Endocrinology Centre of Hoa Binh province from 1/10/1998-1/10/2000. Results of the study were used by biological statistic with the software SPSS 10.0. Results showed that: Among all samples, 78.89% of patients were effectively treated. All the symptoms (except proptosis) and basic metabolic data were improved. ECG and thyroid ultrasound examination results were also significantly improved. However, the rate of compliance was relatively low. Only 26.11% of patients completed all 3 stages of the clinical trial
Graves Disease ; Therapeutics ; Endocrinology

175 Basedow’s disease patients (45 males and 170 females; mean age: 44.48 ± 8.89) were treated by I-131 at Bach Mai hospital and Military Hospital 103. Total T3 level in serum was 6.45 ± 2.81 nmol/l (n=146) and total T4 level was 243.58 ± 72.34 nmol/l (n=143). Before treatment T3 and T4 level increased abnormaly comparing with healthy people. By 4 months of treatment, T3 level was 2.15 ± 0.78 nmol/l and T4 level was 120.35 ± 36.81nmol/l, FT4 level was 15.67 ± 6.51pmol/l. With average dose of 6.52 ± 1.64 mCi I-131, most of patients had normalized total T3, T4 level
Graves Disease ; Therapeutics

TRAb concentration in the blood of healthy adults and Basedow patients before and after I-131 treatment was measured by RIA (Radioimmunoassay) method. The results were as follow: RIA method for measuring TRAb was standardized. TRAb concentration in the blood of healthy adults was in the very low level (undetectable). TRAb concentrations in the Basedow patients before I-131 treatment were 426.98+/-206.21 mU/ml and by many times higher than that of healthy adults. After I-131 treatment: TRAb concentrations in the 5/12 Basedow patients could not be measured (undetectable) and in 7/12 patients were 127.67+/-59.21 mU/ml.
Graves Disease ; Antibodies ; blood

410 patients with the basedow in the nuclear medicine department of Da Nang hospital were treated by radioiodine I-131. The age, gender and geographic area, progress of the disease as year and classification of the disease, the size of nodules,.. and cardiac complications were analysed. The average rounds of therapy and condition of hypothyroidism were also evaluated.
Graves Disease ; therapy

The study on arrhythmia in patient with basedow was carried out from which some method of treatment and prevention of complication of arrhythmia due to basedow was introduced. Subjects: 2758 patients in National Institute of endocrine during 9/1994 - 9/1996, in which: goiter: 923; basedow: 1838. Results: complications (66,8%) in which mild cardiac complication such as ventricular conductive disorder : 464 cases (25.2%). In 1838 patients female 93.3%, ages of 31 -50.
Graves Disease ; complications